Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02075918 · ClinicalTrials.gov registry record
Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 376
- Enrollment target
NCT02075918: Completed study, sponsored by University of Pittsburgh.
NCT02075918 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 376 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02075918 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 376 participants
- Enrollment target
Study Summary
Purpose: To improve the diagnosis and assessment of severity of acute alcoholic hepatitis Participants: Patients admitted to one of ten centers with acute alcoholic hepatitis Procedures (methods): Consecutive patients admitted with acute alcoholic hepatitis will be enrolled in an NIH U01 study of acute alcoholic hepatitis where liver tissue, blood and stool will be collected to discover and validate factors associated with diagnosis, severity of disease and survival.
Primary Outcome
Utilizing liver tissue, blood samples, and stool and urine samples, InTeam will aim to discover and validate factors associated with the diagnosis and severity of Alcoholic hepatitis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2014-05 |
| Est. Completion | 2019-05-31 |
What the finished NCT02075918 record still lists
NCT02075918 is an observational study that tracks outcomes without assigning an intervention. The registered 376 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02075918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02075918 about?
NCT02075918 is a clinical study titled "Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis". Purpose: To improve the diagnosis and assessment of severity of acute alcoholic hepatitis Participants: Patients admitted to one of ten centers with acute alcoholic hepatitis Procedures (methods): Consecutive patients admitted with acute alcoholic hepatitis will be enrolled in an NIH U01 study of ac...
What is the current status of trial NCT02075918?
This trial is currently completed. The enrollment target is 376 participants. The study started on 2014-05. Estimated completion is 2019-05-31.
Who is sponsoring clinical trial NCT02075918?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03102125 · 376 participants · Phase 4
Allograft Dysfunction in Heart Transplant
- NCT05055297 · 376 participants · NA
SELUTION4BTK Trial
- NCT05912647 · 376 participants · NA
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
- NCT05963971 · 376 participants · NA
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia